[go: up one dir, main page]

BR8802840A - Processo para a preparacao de um conjugado de acido hialuronico - Google Patents

Processo para a preparacao de um conjugado de acido hialuronico

Info

Publication number
BR8802840A
BR8802840A BR8802840A BR8802840A BR8802840A BR 8802840 A BR8802840 A BR 8802840A BR 8802840 A BR8802840 A BR 8802840A BR 8802840 A BR8802840 A BR 8802840A BR 8802840 A BR8802840 A BR 8802840A
Authority
BR
Brazil
Prior art keywords
preparation
hyaluronic acid
acid conjugate
conjugate
hyaluronic
Prior art date
Application number
BR8802840A
Other languages
English (en)
Inventor
Derek Clifford Ellwood
Original Assignee
Skandigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skandigen Ab filed Critical Skandigen Ab
Publication of BR8802840A publication Critical patent/BR8802840A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR8802840A 1987-06-11 1988-06-10 Processo para a preparacao de um conjugado de acido hialuronico BR8802840A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878713662A GB8713662D0 (en) 1987-06-11 1987-06-11 Hyaluronic acid derivatives

Publications (1)

Publication Number Publication Date
BR8802840A true BR8802840A (pt) 1989-01-03

Family

ID=10618743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8802840A BR8802840A (pt) 1987-06-11 1988-06-10 Processo para a preparacao de um conjugado de acido hialuronico

Country Status (6)

Country Link
EP (1) EP0296740A3 (pt)
JP (1) JP2701865B2 (pt)
BR (1) BR8802840A (pt)
GB (2) GB8713662D0 (pt)
HU (1) HUT47138A (pt)
IL (1) IL86671A (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
EP0506976B1 (en) * 1990-10-18 1997-04-09 Shiseido Company Limited Combination of hyaluronic acid with medicinal ingredient and production thereof
JPH0784481B2 (ja) * 1991-02-21 1995-09-13 株式会社デイ・デイ・エス研究所 カルボキシメチルマンノグルカン及びその誘導体
WO1992015299A1 (en) * 1991-03-05 1992-09-17 Bloom, Leonard Topical treatment of acne
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6136793A (en) * 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5612321A (en) † 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
JP2001081103A (ja) * 1999-09-13 2001-03-27 Denki Kagaku Kogyo Kk ヒアルロン酸結合薬剤
JP4450456B2 (ja) * 1999-09-27 2010-04-14 株式会社マルハニチロ水産 皮脂産生抑制剤
ITPD20020271A1 (it) * 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
US7858080B2 (en) 2005-05-20 2010-12-28 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
EP1888651B1 (en) * 2005-05-20 2014-07-30 Agency for Science, Technology and Research Aldehyde conjugated flavonoid preparations
IE20060049A1 (en) * 2006-01-25 2007-08-08 Eurand Pharmaceuticals Ltd A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents
AU2007295894B2 (en) 2006-09-13 2013-10-17 Enhance Skin Products, Inc. Cosmetic composition for the treatment of skin and methods thereof
JP2015533190A (ja) 2012-10-09 2015-11-19 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 修飾されたヒアルロン酸誘導体およびその使用
WO2014127418A1 (en) * 2013-02-20 2014-08-28 The University Of Queensland Conjugate compound and uses of same
US9572832B2 (en) * 2013-08-29 2017-02-21 Holy Stone Healthcare Co., Ltd. Compound of glycosaminoglycan and its fabrication method as well as application
WO2015174934A1 (en) 2014-05-15 2015-11-19 Agency For Science, Technology And Research Polymer-flavonoid conjugate and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
CA1188988A (en) * 1981-07-02 1985-06-18 Alan G. Walton Chondroitin drug complexes
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
US5785334A (en) * 1995-11-22 1998-07-28 Robinson; Russell S. Bicycle towable collapsible cart

Also Published As

Publication number Publication date
GB8813763D0 (en) 1988-07-13
IL86671A (en) 1992-12-01
EP0296740A3 (en) 1989-06-14
HUT47138A (en) 1989-01-30
EP0296740A2 (en) 1988-12-28
IL86671A0 (en) 1988-11-30
GB2207142B (en) 1990-10-31
JP2701865B2 (ja) 1998-01-21
GB2207142A (en) 1989-01-25
GB8713662D0 (en) 1987-07-15
JPS6454002A (en) 1989-03-01

Similar Documents

Publication Publication Date Title
BR8802840A (pt) Processo para a preparacao de um conjugado de acido hialuronico
BR8803908A (pt) Processo para a preparacao de um polimero de 1-olefina
BR8802484A (pt) Processo para a preparacao de isocianatos
PT88044A (pt) Processo para a preparacao de acidos tetra-hidrocarbazole-1-alcanoicos
PT82342B (pt) Processo para a preparacao de derivados do acido hialuronico
PT86312A (pt) Processo para a preparacao de fibras superabsorventes
PT92919A (pt) Processo para a preparacao de agentes ansioliticos bis-azabiciclicos
PT87707A (pt) Processo para a preparacao de derivados de 2-anilino-pirimidina
BR9105080A (pt) Processo para a preparacao de um acido alcoxialcanoico
BR8804284A (pt) Processo para a preparacao de acidos etercarboxilicos
PT89075A (pt) Processo para a preparacao de diacidos diarilestiril-quinolinicos
BR8801269A (pt) Processo para a preparacao de um composto de ciano-imidazol
PT83332A (pt) Processo aperfeicoado para a preparacao de acido tetrafluorobenzoico
BR8702112A (pt) Processo para a preparacao de um derivado de pirazol pirimidina
PT88365A (pt) Processo para a preparacao de acidos 2-fenil-4-quinolino-carboxilicos substituidos
PT89039A (pt) Processo para a preparacao de l-ramnose
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT88078A (pt) Processo para a preparacao de acidos quinolonocarboxilicos
BR8803678A (pt) Processo para a preparacao de polieteramidas
PT89056A (pt) Processo para a preparacao de hidroxilaminas substituidas
BR8807384A (pt) Processo para a preparacao de anidridos oxi-diftalicos
PT84073B (pt) Processo para a preparacao de lactamas aminoglicosidicas do acido nor-colanico
PT88924A (pt) Processo para a preparacao de derivados de ginkgolidos
PT80988B (pt) Processo para a preparacao de derivados de acido quinolocarboxilico
BR8806351A (pt) Processo para a preparacao de fenil-ureias

Legal Events

Date Code Title Description
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C08B 37/08 (2006.01), A61K 47/61 (2017.0